引用本文:
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3008次   下载 2785 本文二维码信息
码上扫一扫!
分享到: 微信 更多
连续性肾脏替代治疗在伴利尿剂抵抗的2型心肾综合征中的应用价值
徐建国, 徐敏, 张雪良, 潘娅静
温州市人民医院ICU
摘要:
目的 探讨连续性肾脏替代治疗(CRRT)在伴利尿剂抵抗的2型心肾综合征中的应用价值。方法 收集伴利尿剂抵抗的2型心肾综合征患者41例,入ICU后予CRRT治疗,观察CRRT治疗前后平均动脉压、中心静脉压、休克指数、氧合指数、尿量、血浆氨基末端B型利钠肽前体、肌酐、碳酸氢根等临床数据及血清TNF-α、IL-1β、IL-6、C反应蛋白(CRP)等炎症因子水平的变化。结果CRRT治疗后,患者中心静脉压、氧合指数、尿量、血浆氨基末端B型利钠肽前体、肌酐、碳酸氢根及炎性细胞因子TNF-α、IL-1β、IL-6水平较治疗前明显好转(均P<0.05),而平均动脉压、休克指数、超声心动图及CRP水平均无明显变化(均P>0.05)。结论CRRT对伴利尿剂抵抗的2型心肾综合征,尤其是重症心肾综合征患者有极大的应用价值。
关键词:  连续性肾脏替代治疗 2 型心肾综合征 利尿剂抵抗 治疗
DOI:
分类号:
基金项目:温州市科技局基金资助项目
Continuous renal replacement therapy in treatment of type 2 cardiorenal syndrome with diuretic resistance
XU Jianguo, XU Min, ZHANG Xueliang, PAN Yajing
Wenzhou People's Hospital
Abstract:
Objective The evaluate the application of continuous renal replacement therapy (CRRT) in treatment of type 2 cardiorenal syndrome with diuretic resistance. Methods Forty one patients with type 2 cardiorenal syndrome and di- uretic resistance admitted in ICU of Wenzhou People's Hospital were enrolled in this study. Patients received continuous renal re- placement therapy after admission. The mean arterial pressure, central venous pressure, shock index, oxygenation index, urine, plasma amino-terminal pro-B-type natriuretic peptide precursor, creatinine , bicarbonate and serum inflammatory cytokines TNF-α, IL-1β, IL-6, CRP in type 2 cardiorenal syndrome patients were measured before and after treatment. Results After CRRT treatment, the central venous pressure, oxygenation index, urine, plasma amino-terminal pro-B-type natriuretic peptide precursor, creatinine , bicarbonate, TNF-α, IL-1βand IL-6 were significantly improved(P<0.05). The mean arterial blood pres- sure, shock index, echocardiography and CRP were not significantly changed (P >0.05). Conclusion For type 2 cardiorenal syndrome, especially critical patients with serious diuretic resistance, CRRT is of therapeutic value.
Key words:  Continuous renal replacement therapy Type2 cardiorenal syndrome Diuretic resistance Treatment